Olema Pharmaceuticals announces annual shareholder meeting via webcast

• Olema Pharmaceuticals will hold its annual stockholders meeting virtually on June 17, 2026.
• Stockholders will vote on election of four Class III directors to terms ending at 2029 annual meeting.
• Advisory vote scheduled on compensation for named executive officers.
• Ernst & Young LLP appointment slated for ratification as independent registered public accounting firm for year ending Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olema Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-191956), on April 29, 2026, and is solely responsible for the information contained therein.